You just read:

Eisai Announces Lorcaserin HCl CAMELLIA-TIMI 61 Study will Continue as Planned Based on Interim Safety Analysis by Independent Data Monitoring Committee (DMC)

News provided by

Eisai Inc.

Jun 21, 2017, 08:02 ET